A gene made people like onions, and onions made them healthier.
Buried in the architecture of human DNA lies a quiet arbiter of appetite — and for those who carry a particular variant of the olfactory receptor gene OR2T6, a lifelong pull toward onions may be quietly guarding their cardiovascular and metabolic health. Researchers from the Monell Chemical Senses Center and partner institutions have used a method called Mendelian randomization to do what nutrition science has long struggled to accomplish: establish that a specific food genuinely causes measurable health benefits, rather than merely accompanying a healthier life. Published in BMC Medicine, the findings mark a methodological turning point — one that grounds dietary wisdom not in statistical patterns easily distorted by wealth or habit, but in the inherited biology of taste and smell itself.
- For decades, nutrition research has been trapped in a frustrating paradox: the people who eat well also live well in every other way, making it nearly impossible to isolate what the food itself is actually doing.
- The Mendelian randomization method cuts through this noise by treating genetic inheritance — fixed at birth, immune to lifestyle choices — as a natural experiment that assigns dietary tendencies without the researcher's hand.
- Screening over 1,200 genetic variants across hundreds of taste and smell receptor genes in nearly 500,000 adults, the team identified a single olfactory gene, OR2T6, as a reliable predictor of onion preference and consumption.
- Carriers of the onion-favoring variant showed systolic blood pressure roughly 1.3 mmHg lower and a 14 percent reduced risk of type 2 diabetes — with no corresponding effect on BMI or blood fats, suggesting the benefit is specific to onions rather than a general health halo.
- The framework now points toward a future of personalized nutrition grounded in chemosensory genetics, where dietary recommendations might be tailored to the biological reality of how each person tastes and smells the world.
There is a gene in human DNA that quietly steers some people toward onions — and researchers have now shown that following that pull may carry real consequences for the heart and the pancreas. Scientists from the Monell Chemical Senses Center in Philadelphia, collaborating with teams at the NIH, the University of Queensland, the University of Bristol, and QIMR Berghofer, identified a genetic variant linked to onion preference that correlates with lower blood pressure and a roughly 14 percent reduction in type 2 diabetes risk. The findings, published in BMC Medicine, address a problem that has haunted nutrition science for generations.
The difficulty has always been the same: people who eat vegetables also tend to exercise, avoid smoking, and have more resources. Correlation masquerades as causation, and the randomized controlled trials that would settle the question are practically impossible to run over the timescales diet requires. The team's solution was Mendelian randomization — a method that uses inherited genetic variants as stand-ins for dietary behavior. Because the version of a gene you carry is determined by chance at birth, not by your choices or your health, it can serve as an unbiased proxy for preference, sidestepping the confounding that has undermined observational nutrition research.
The researchers screened more than 1,200 variants across 325 taste and smell receptor genes using UK Biobank data from nearly 500,000 adults, ultimately identifying 25 robust genetic instruments for 20 different foods. One rose above the rest: OR2T6, an olfactory receptor gene that predicts how much a person likes onions. Using it as a genetic proxy, the team found that people genetically inclined toward onions had measurably lower systolic and diastolic blood pressure and a significantly reduced diabetes risk — with no effect on body weight or blood fats, suggesting the benefit is specific rather than a reflection of generally healthier living.
Onions are rich in quercetin and other anti-inflammatory compounds, offering a plausible biological mechanism for the findings. But the deeper significance lies in the method itself. By anchoring dietary analysis in the biology of chemosensation rather than in observational patterns, this approach opens a path toward personalized nutrition recommendations built on genetic taste profiles — a potential transformation in how science connects what we eat to how we live.
There's a gene in your DNA that might be quietly steering you toward onions—and if you carry the right version of it, that preference could be protecting your heart and your pancreas. Researchers from the Monell Chemical Senses Center in Philadelphia, working alongside teams at the National Institutes of Health, the University of Queensland, the University of Bristol, and the QIMR Berghofer Medical Research Institute, have identified a specific genetic variant linked to onion preference that correlates with measurably lower blood pressure and a roughly 14 percent reduction in type 2 diabetes risk. The findings, published in BMC Medicine, represent a breakthrough in how scientists can actually prove that certain foods are genuinely good for you—a question that has plagued nutrition research for decades.
The core problem nutrition science has always faced is devilishly simple: people who eat lots of vegetables tend to be healthier, but they also tend to exercise more, smoke less, and have more money. Correlation is not causation. The gold standard for proving causation—the randomized controlled trial—is almost impossible to run in nutrition studies. You can't ask people to eat a specific diet for twenty years and measure what happens. The time, the cost, the logistics make it impractical. So researchers have been stuck, unable to definitively separate the food from the lifestyle, the diet from the person living it.
The team deployed a method called Mendelian randomization, which uses genetics as a natural experiment. The version of a gene you inherit is determined by chance at birth, not by your choices or your health status. By identifying genetic variants that influence taste and smell—the fundamental biology of how we experience food—the researchers could use those variants as proxies for dietary preference. This sidesteps the problem of people misremembering what they ate, or changing their diet because they're already sick. As Danielle Reed, the Monell Center's chief science officer, explained it: the approach grounds the analysis in chemosensory biology, avoiding the trap that has caught nutritional epidemiology for decades.
The researchers screened over 1,200 genetic variants across 325 taste and smell receptor genes using data from the UK Biobank, a study of nearly 500,000 British adults. They found 268 variants across 117 different receptor genes that predicted preferences for 96 different foods—everything from garlic and grapefruit to horseradish, broad beans, and aniseed. They then validated these findings in a separate, younger population from Bristol, confirmed that the same genes predicted actual food consumption (not just preference), and filtered out variants that might be confounded by wealth or social factors. What remained were 25 robust genetic instruments for 20 foods. One stood out: a gene called OR2T6, an olfactory receptor that predicts how much a person likes onions.
Using OR2T6 as a genetic proxy for onion preference, the team tested whether people genetically inclined to eat more onions actually had better health outcomes. They did. People carrying the variant linked to greater onion liking had, on average, systolic blood pressure that was approximately 1.3 millimeters of mercury lower per point on the liking scale, and diastolic blood pressure roughly 0.7 millimeters lower. They also showed a 14 percent reduced risk of developing type 2 diabetes. Notably, there was no effect on body mass index, blood fats, or blood sugar levels—suggesting this wasn't simply a case of onion eaters being generally healthier people. The benefit appeared specific to onions themselves.
Onions are rich in quercetin and other compounds with documented anti-inflammatory and cardiovascular properties, which provides a plausible biological explanation for the findings. Previous laboratory studies and small human trials had hinted at these benefits, but the evidence was weak. This genetic approach provides much firmer ground. By anchoring the analysis in the biology of taste and smell rather than in observational patterns, the method is far more resistant to the confounding and reverse causation that have undermined nutritional epidemiology for decades. Reed described it as a new way of asking whether a food is genuinely good for you—one that doesn't depend on statistical signals that might simply be picking up on the fact that sick people change their diets. The implications extend beyond onions. This framework could eventually enable personalized nutrition recommendations based on genetic taste profiles, transforming how we think about diet and disease prevention.
Citações Notáveis
We used Mendelian randomization—genetic analysis—to address this challenge. Long-term randomized controlled trials are simply not feasible in nutrition.— Danielle Reed, Monell Chemical Senses Center Chief Science Officer
What we've built is essentially a new way of asking whether a food is genuinely good for you. Grounding the instruments in chemosensory biology helps avoid the trap of picking up on the fact that sick people change their diets.— Danielle Reed
A Conversa do Hearth Outra perspectiva sobre a história
So you're saying a gene made people like onions, and that liking onions made them healthier? That sounds almost too neat.
It's not quite that simple. The gene predicts preference—it makes onions taste better to you. But the health benefit comes from actually eating them. The gene is just the instrument that lets us prove the food itself matters, separate from everything else about how that person lives.
Why is that distinction so important?
Because for decades, when researchers found that vegetable eaters were healthier, they couldn't tell if it was the vegetables or the fact that healthy people tend to make healthy choices across the board. This method uses genetics as a randomizer—you don't choose your genes, so we can isolate the food's actual effect.
And this only worked for onions?
No, they found 25 robust genetic instruments for 20 different foods. But onions were the clearest signal—the gene predicted preference in both old and young people, predicted actual consumption, and showed no connection to wealth or unrelated diseases.
What happens next? Do doctors start testing people's taste genes?
Not yet. This is proof of concept. But if the method holds up across more foods, it could eventually reshape how we give dietary advice—moving from general recommendations to something based on what your biology actually responds to.